Class Action Lawsuit On Behalf of Certain KV Pharmaceutical Company Investors Filed
DENVER, Dec. 5, 2008 (LAWFUEL) — Dyer & Berens LLP today announced that it has commenced a class action lawsuit in the United States District Court for the Eastern District of Missouri on behalf of purchasers of KV Pharmaceutical Company (“KV” or the “Company”) Class A Common Stock (NYSE:KV-A), Class B Common Stock (NYSE:KV-B) and
Class Action Lawsuit On Behalf of Certain KV Pharmaceutical Company Investors Filed Read More »
